Terry A. Braun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Terry A. Braun has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
Aaron T. Scott
16 shared publications- Dawn E. Quelle
Cancer Biology Graduate Program, University of Iowa, Iowa City, IA 52242, USA
16 shared publications Joseph S. Dillon
16 shared publications- Patrick Breheny
Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA
16 shared publications Shaikamjad Umesalma
16 shared publicationsBart J. Brown
15 shared publications
Latest Publications
- Open Access
- 13 August 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (8) , e0355832
Genome-wide machine learning analysis of anosmia and ageusia with COVID-19
The COVID-19 pandemic has caused substantial worldwide disruptions in health, economy, and society, manifesting symptoms such as loss of smell (anosmia) and loss of taste (ageusia), that can result in prolonged sensory impairment. Establishing the host genetic etiology of anosmia and ageusia in COVID-19 will aid in the overall understanding of the sensorineural aspect of the disease and contribute to possible treatments or cures. By using human genome sequencing data from the University of Iowa (UI) COVID-19 cohort (N = 187) and the National Institute of Health All of Us (AoU) Research Program COVID-19 cohort (N = 947), we investigated the genetics of anosmia and/or ageusia by employing feature selection techniques to construct a novel variant and gene prioritization pipeline, utilizing machine learning methods for the classification of patients. Models were assessed using a permutation-based variable importance (PVI) strategy for final prioritization of candidate variants and genes. The highest held-out test set area under the receiver operating characteristic (AUROC) curve for models and datasets from the UI cohort was 0.735 and 0.798 for the variant and gene analysis respectively and for the AoU cohort was 0.687 for the variant analysis. Our analysis prioritized several novel and known candidate host genetic factors involved in immune response, neuronal signaling, and calcium signaling supporting previously proposed hypotheses for anosmia/ageusia in COVID-19.
- 13 August 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (8) , e0355832
Open AccessGenome-wide machine learning analysis of anosmia and ageusia with COVID-19
The COVID-19 pandemic has caused substantial worldwide disruptions in health, economy, and society, manifesting symptoms such as loss of smell (anosmia) and loss of taste (ageusia), that can result in prolonged sensory impairment. Establishing the host genetic etiology of anosmia and ageusia in COVID-19 will aid in the overall understanding of the sensorineural aspect of the disease and contribute to possible treatments or cures. By using human genome sequencing data from the University of Iowa (UI) COVID-19 cohort (N = 187) and the National Institute of Health All of Us (AoU) Research Program COVID-19 cohort (N = 947), we investigated the genetics of anosmia and/or ageusia by employing feature selection techniques to construct a novel variant and gene prioritization pipeline, utilizing machine learning methods for the classification of patients. Models were assessed using a permutation-based variable importance (PVI) strategy for final prioritization of candidate variants and genes. The highest held-out test set area under the receiver operating characteristic (AUROC) curve for models and datasets from the UI cohort was 0.735 and 0.798 for the variant and gene analysis respectively and for the AoU cohort was 0.687 for the variant analysis. Our analysis prioritized several novel and known candidate host genetic factors involved in immune response, neuronal signaling, and calcium signaling supporting previously proposed hypotheses for anosmia/ageusia in COVID-19.
- Open Access
- 14 April 2026
- Published by JMIR Publications Inc. in JMIR Bioinformatics and Biotechnology
- Vol. 7, e85212
The AudioGene Translational Dashboard for Diagnosing Autosomal Dominant Nonsyndromic Hearing Loss: Phenotypic Data Visualization and Analysis Study
Background: Autosomal dominant nonsyndromic hearing loss (ADNSHL) is highly heterogeneous, with more than 64 genes implicated in its etiology. This complexity limits the diagnostic power of clinical examinations and audiometry alone, while existing computational approaches have achieved only moderate accuracy and often lack interpretability. As precision medicine increasingly emphasizes genotype-phenotype correlations, there is a recognized need for diagnostic tools that provide clinicians with transparent, interpretable outputs. Objective: This study aimed to develop and evaluate the AudioGene Translational Dashboard, an interpretable clinical informatics tool that integrates machine learning models and interactive visualizations to enhance genotype-phenotype correlations and support diagnostic decision-making in ADNSHL. Methods: We developed the AudioGene Translational Dashboard, integrating 2 machine learning models (AudioGene version 4 and AudioGene version 9.1) with 6 interactive visualization tools. AudioGene version 4 uses a multi-instance support vector machine classifier for patients with multiple audiograms, while AudioGene version 9.1 combines adaptive boosting, k-nearest neighbors, random forest models, and logistic regression for patients with a single audiogram. Visualizations include audiometric profile plots, audioprofile surfaces, clustering analyses, and data distribution charts designed to facilitate clinical interpretation. Results: The AudioGene Translational Dashboard was developed to address the “70/30” phenomenon, indicating a 74% likelihood that the causative gene is among the top 3 predicted genes, thereby providing clinicians with a clear confidence indicator (“green flag”) or a caution alert (“red flag”) during diagnosis. While this level of performance is well suited for hypothesis generation, the remaining uncertainty underscores the need for interpretive context in clinical decision-making. Visualization tools enhanced clinicians’ ability to interpret and correlate phenotypic data with predicted genetic outcomes, improving diagnostic confidence and interpretability. Conclusions: The AudioGene Translational Dashboard advances clinical informatics in genetic diagnosis of ADNSHL by integrating explainable artificial intelligence with interactive visualizations, enhancing clinical interpretability and diagnostic accuracy. This approach facilitates informed clinical decision-making, highlights the translational potential of genotype-phenotype computational models, and supports precision medicine in hearing loss diagnostics. Future enhancements will target improving class balance and incorporating additional user-customizable features to further optimize clinical applicability.
- 14 April 2026
- Published by JMIR Publications Inc. in JMIR Bioinformatics and Biotechnology
- Vol. 7, e85212
Open AccessThe AudioGene Translational Dashboard for Diagnosing Autosomal Dominant Nonsyndromic Hearing Loss: Phenotypic Data Visualization and Analysis Study
Background: Autosomal dominant nonsyndromic hearing loss (ADNSHL) is highly heterogeneous, with more than 64 genes implicated in its etiology. This complexity limits the diagnostic power of clinical examinations and audiometry alone, while existing computational approaches have achieved only moderate accuracy and often lack interpretability. As precision medicine increasingly emphasizes genotype-phenotype correlations, there is a recognized need for diagnostic tools that provide clinicians with transparent, interpretable outputs. Objective: This study aimed to develop and evaluate the AudioGene Translational Dashboard, an interpretable clinical informatics tool that integrates machine learning models and interactive visualizations to enhance genotype-phenotype correlations and support diagnostic decision-making in ADNSHL. Methods: We developed the AudioGene Translational Dashboard, integrating 2 machine learning models (AudioGene version 4 and AudioGene version 9.1) with 6 interactive visualization tools. AudioGene version 4 uses a multi-instance support vector machine classifier for patients with multiple audiograms, while AudioGene version 9.1 combines adaptive boosting, k-nearest neighbors, random forest models, and logistic regression for patients with a single audiogram. Visualizations include audiometric profile plots, audioprofile surfaces, clustering analyses, and data distribution charts designed to facilitate clinical interpretation. Results: The AudioGene Translational Dashboard was developed to address the “70/30” phenomenon, indicating a 74% likelihood that the causative gene is among the top 3 predicted genes, thereby providing clinicians with a clear confidence indicator (“green flag”) or a caution alert (“red flag”) during diagnosis. While this level of performance is well suited for hypothesis generation, the remaining uncertainty underscores the need for interpretive context in clinical decision-making. Visualization tools enhanced clinicians’ ability to interpret and correlate phenotypic data with predicted genetic outcomes, improving diagnostic confidence and interpretability. Conclusions: The AudioGene Translational Dashboard advances clinical informatics in genetic diagnosis of ADNSHL by integrating explainable artificial intelligence with interactive visualizations, enhancing clinical interpretability and diagnostic accuracy. This approach facilitates informed clinical decision-making, highlights the translational potential of genotype-phenotype computational models, and supports precision medicine in hearing loss diagnostics. Future enhancements will target improving class balance and incorporating additional user-customizable features to further optimize clinical applicability.
- 30 October 2025
- Published by The University of Iowa
Transcriptomic and metagenomic characteristics of visceral leishmaniasis
Leishmaniasis is a group of diseases caused by the parasitic protozoa belonging to the genus, Leishmania. Visceral leishmaniasis (VL) is the severest of the syndromes, causing the majority of fatalities due to leishmaniasis. The disease is usually vector-borne, caused by a bite from a female phlebotomine sand fly. VL is prevalent in endemic regions often associated with poverty. The regions of the world where symptomatic visceral leishmaniasis occurs most commonly include India, the adjoining regions of Bangladesh and Nepal, Brazil, and countries in eastern Africa. A majority of cases are asymptomatic, leading us to question what host factors predispose individuals to develop symptomatic VL. To investigate host factors contributing to the outcome of VL, our collaborators in Varanasi, India purified CD4+ T-cells and CD14+ myeloid cells from peripheral blood or bone marrow of twelve patients with VL, prior to treatment. In parallel, control subjects from the endemic region who underwent bone marrow aspirates for unrelated conditions were also recruited. These subjects had a variety of underlying disorders and required downstream evaluation due to their final diagnoses. In this thesis we describe the evaluation of transcriptomes of the two cell types in blood and bone marrow aspirate cells from these twenty-four subjects, using RNA sequencing. These transcriptomes were aligned to the human genome assembly GRCh38 using the publicly available programs HISAT2, featureCounts, and DESeq2. The differential expression profiles validate some observations made in the literature but also raised a number of pathways and transcripts that deserve further investigation. Examples are the possible activation of the AIM2 inflammasome during infection, and the prominence of the IL17 pathway. In chapter 3 we investigated transcriptomes of both CD4+ and CD14+ cells from the same subjects, and these highlighted the possibility that some samples had been erroneously labeled at some point in the processing, necessitating removal from the final study. Pathways in the combined analyses were used to conduct pathway analyses with the Ingenuity Pathway Analysis program. Finally, the unmapped reads from the original RNA-seq alignments were investigated using the Kraken2 suite of programs and used to detect and quantify Leishmania donovani sequences in blood and bone marrow of infected subjects. Overall, the data provide insight into the biological status of subjects with VL and their infecting organisms.
- 30 October 2025
- Published by The University of Iowa
Transcriptomic and metagenomic characteristics of visceral leishmaniasis
Leishmaniasis is a group of diseases caused by the parasitic protozoa belonging to the genus, Leishmania. Visceral leishmaniasis (VL) is the severest of the syndromes, causing the majority of fatalities due to leishmaniasis. The disease is usually vector-borne, caused by a bite from a female phlebotomine sand fly. VL is prevalent in endemic regions often associated with poverty. The regions of the world where symptomatic visceral leishmaniasis occurs most commonly include India, the adjoining regions of Bangladesh and Nepal, Brazil, and countries in eastern Africa. A majority of cases are asymptomatic, leading us to question what host factors predispose individuals to develop symptomatic VL. To investigate host factors contributing to the outcome of VL, our collaborators in Varanasi, India purified CD4+ T-cells and CD14+ myeloid cells from peripheral blood or bone marrow of twelve patients with VL, prior to treatment. In parallel, control subjects from the endemic region who underwent bone marrow aspirates for unrelated conditions were also recruited. These subjects had a variety of underlying disorders and required downstream evaluation due to their final diagnoses. In this thesis we describe the evaluation of transcriptomes of the two cell types in blood and bone marrow aspirate cells from these twenty-four subjects, using RNA sequencing. These transcriptomes were aligned to the human genome assembly GRCh38 using the publicly available programs HISAT2, featureCounts, and DESeq2. The differential expression profiles validate some observations made in the literature but also raised a number of pathways and transcripts that deserve further investigation. Examples are the possible activation of the AIM2 inflammasome during infection, and the prominence of the IL17 pathway. In chapter 3 we investigated transcriptomes of both CD4+ and CD14+ cells from the same subjects, and these highlighted the possibility that some samples had been erroneously labeled at some point in the processing, necessitating removal from the final study. Pathways in the combined analyses were used to conduct pathway analyses with the Ingenuity Pathway Analysis program. Finally, the unmapped reads from the original RNA-seq alignments were investigated using the Kraken2 suite of programs and used to detect and quantify Leishmania donovani sequences in blood and bone marrow of infected subjects. Overall, the data provide insight into the biological status of subjects with VL and their infecting organisms.
- Open Access
- 3 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
AGTD: The AudioGene Translational Dashboard: A Comprehensive Tool for the Visualization and Analysis of Phenotypic Data for Diagnosing Autosomal Dominant Non-syndromic Hearing Loss (Preprint)
BACKGROUND Autosomal dominant non-syndromic hearing loss (ADNSHL) is highly heterogeneous, with more than 64 genes implicated in its etiology. This complexity limits the diagnostic power of clinical examinations and audiometry alone, while existing computational approaches have achieved only moderate accuracy and often lack interpretability. As precision medicine increasingly emphasizes genotype-phenotype correlations, there is a pressing need for diagnostic tools that provide clinicians with transparent, interpretable outputs. OBJECTIVE This study aimed to develop and evaluate the AudioGene Translational Dashboard (AGTD), an interpretable clinical informatics tool that integrates machine learning models and interactive visualizations to enhance genotype–phenotype correlation and support diagnostic decision-making in autosomal dominant non-syndromic hearing loss (ADNSHL). METHODS We developed the AGTD, integrating two sophisticated machine learning models (AG4 and AG9.1) with six interactive visualization tools. AG4 utilizes a multi-instance support vector machine classifier for patients with multiple audiograms, while AG9.1 combines adaptive boosting, k-nearest neighbors, random forest models, and logistic regression for patients with a single audiogram. Visualizations include audiometric profile plots, Audioprofile surfaces, clustering analyses, and data distribution charts designed to facilitate clinical interpretation. RESULTS AGTD introduced the ‘70/30’ rule, indicating a 74% likelihood that the causative gene is among the top three predicted genes, thereby providing clinicians a clear confidence indicator ('green flag') or caution alert ('red flag') during diagnosis. Visualization tools significantly enhanced clinicians' ability to interpret and correlate phenotypic data with predicted genetic outcomes, improving diagnostic confidence and interpretability. CONCLUSIONS The AGTD significantly advances clinical informatics in genetic diagnostics of ADNSHL by integrating explainable AI and interactive visualizations, enhancing clinical interpretability and diagnostic accuracy. This approach facilitates informed clinical decision-making, highlights the translational potential of genotype-phenotype computational models, and supports precision medicine in hearing loss diagnostics. Future enhancements will target improving class balance and incorporating additional user-customizable features to further optimize clinical applicability.
- 3 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAGTD: The AudioGene Translational Dashboard: A Comprehensive Tool for the Visualization and Analysis of Phenotypic Data for Diagnosing Autosomal Dominant Non-syndromic Hearing Loss (Preprint)
BACKGROUND Autosomal dominant non-syndromic hearing loss (ADNSHL) is highly heterogeneous, with more than 64 genes implicated in its etiology. This complexity limits the diagnostic power of clinical examinations and audiometry alone, while existing computational approaches have achieved only moderate accuracy and often lack interpretability. As precision medicine increasingly emphasizes genotype-phenotype correlations, there is a pressing need for diagnostic tools that provide clinicians with transparent, interpretable outputs. OBJECTIVE This study aimed to develop and evaluate the AudioGene Translational Dashboard (AGTD), an interpretable clinical informatics tool that integrates machine learning models and interactive visualizations to enhance genotype–phenotype correlation and support diagnostic decision-making in autosomal dominant non-syndromic hearing loss (ADNSHL). METHODS We developed the AGTD, integrating two sophisticated machine learning models (AG4 and AG9.1) with six interactive visualization tools. AG4 utilizes a multi-instance support vector machine classifier for patients with multiple audiograms, while AG9.1 combines adaptive boosting, k-nearest neighbors, random forest models, and logistic regression for patients with a single audiogram. Visualizations include audiometric profile plots, Audioprofile surfaces, clustering analyses, and data distribution charts designed to facilitate clinical interpretation. RESULTS AGTD introduced the ‘70/30’ rule, indicating a 74% likelihood that the causative gene is among the top three predicted genes, thereby providing clinicians a clear confidence indicator ('green flag') or caution alert ('red flag') during diagnosis. Visualization tools significantly enhanced clinicians' ability to interpret and correlate phenotypic data with predicted genetic outcomes, improving diagnostic confidence and interpretability. CONCLUSIONS The AGTD significantly advances clinical informatics in genetic diagnostics of ADNSHL by integrating explainable AI and interactive visualizations, enhancing clinical interpretability and diagnostic accuracy. This approach facilitates informed clinical decision-making, highlights the translational potential of genotype-phenotype computational models, and supports precision medicine in hearing loss diagnostics. Future enhancements will target improving class balance and incorporating additional user-customizable features to further optimize clinical applicability.
- Open Access
Genome-wide Machine Learning Analysis of Anosmia and Ageusia with COVID-19
The COVID-19 pandemic has caused substantial worldwide disruptions in health, economy, and society, manifesting symptoms such as loss of smell (anosmia) and loss of taste (ageusia), that can result in prolonged sensory impairment. Establishing the host genetic etiology of anosmia and ageusia in COVID-19 will aid in the overall understanding of the sensorineural aspect of the disease and contribute to possible treatments or cures. By using human genome sequencing data from the University of Iowa (UI) COVID-19 cohort (N=187) and the National Institute of Health All of Us (AoU) Research Program COVID-19 cohort (N=947), we investigated the genetics of anosmia and/or ageusia by employing feature selection techniques to construct a novel variant and gene prioritization pipeline, utilizing machine learning methods for the classification of patients. Models were assessed using a permutation-based variable importance (PVI) strategy for final prioritization of candidate variants and genes. The highest held-out test set area under the receiver operating characteristic (AUROC) curve for models and datasets from the UI cohort was 0.735 and 0.798 for the variant and gene analysis respectively and for the AoU cohort was 0.687 for the variant analysis. Our analysis prioritized several novel and known candidate host genetic factors involved in immune response, neuronal signaling, and calcium signaling supporting previously proposed hypotheses for anosmia/ageusia in COVID-19.
Open AccessGenome-wide Machine Learning Analysis of Anosmia and Ageusia with COVID-19
The COVID-19 pandemic has caused substantial worldwide disruptions in health, economy, and society, manifesting symptoms such as loss of smell (anosmia) and loss of taste (ageusia), that can result in prolonged sensory impairment. Establishing the host genetic etiology of anosmia and ageusia in COVID-19 will aid in the overall understanding of the sensorineural aspect of the disease and contribute to possible treatments or cures. By using human genome sequencing data from the University of Iowa (UI) COVID-19 cohort (N=187) and the National Institute of Health All of Us (AoU) Research Program COVID-19 cohort (N=947), we investigated the genetics of anosmia and/or ageusia by employing feature selection techniques to construct a novel variant and gene prioritization pipeline, utilizing machine learning methods for the classification of patients. Models were assessed using a permutation-based variable importance (PVI) strategy for final prioritization of candidate variants and genes. The highest held-out test set area under the receiver operating characteristic (AUROC) curve for models and datasets from the UI cohort was 0.735 and 0.798 for the variant and gene analysis respectively and for the AoU cohort was 0.687 for the variant analysis. Our analysis prioritized several novel and known candidate host genetic factors involved in immune response, neuronal signaling, and calcium signaling supporting previously proposed hypotheses for anosmia/ageusia in COVID-19.